FOXG1 Research Foundation 2024 Q2 Research & Development Update

The FOXG1 Research Foundation is happy to share our 2024 Q2 update on FOXG1 Research and Development from our Chief Scientific Officer, Dr. Soo-Kyung Lee and our Chief Drug Development Officer, Dr. Gai Ayalon.